Cuatrecasas has appointd Gemma Colomer as counsel specialising in Pharmaceutical and Healthcare Law
Tags :Elena Cuatrecasas
Cuatrecasas has advised Deepull Diagnostics in its Series C investment round for 50 million euros. Deepull, a developer of culture-free medical diagnostic solutions, will use the funds to complete clinical validations and advance the regulatory approval
